pharmacie et médicaments – Médicament en accès précoce concernant la SLA

This written question concerns early access to medication for Amyotrophic Lateral Sclerosis (ALS). It seeks information on the procedures and conditions for patients to access new treatments before their official market authorization. This procedure affects patients with ALS, their families, and healthcare providers. It aims to clarify the framework for compassionate use or early access programs for innovative therapies.